Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The new study showed that results for Black women on the breast cancer test Oncotype DX may be inaccurate.
The new consensus guidelines apply to women who have had breast cancer in the past and were at least 75 years old.
A meta-analysis of 18 studies found that late diagnosis and mortality were significantly higher among American women than African women.
Data show that 1 in 5 men and women worldwide develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease.
Cholesterol-lowering meds may reduce cardiotoxic chemotherapy side effects in women with early breast cancer.
New study reveals that more work is needed to enhance adherence to recommended cancer screening in Canada.
Using birth control correlates to a small increase in breast cancer risk but a larger, permanent drop in ovarian and endometrial cancer.
The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.
Faster recovery is a common reason women with breast cancer forgo reconstructive surgery after a mastectomy.
Women who stuck to a diabetes risk reduction diet after receiving a breast cancer diagnosis had a lower risk of death from breast cancer.
COVID-19, FDA drug approvals and new approaches to treatment and quality of life stood out among this year’s top stories.
Study offers assurance that the benefits of the combination can be achieved without diminishing patients’ quality of life.
Meditation and survivorship classes can both ease depressive symptoms, but meditation also boosts energy.
The oral targeted therapy Verzenio reduced relapse risk in extended follow-up from a recent study.
Here’s a list of the approved drugs to treat breast cancer. Click on any of the medications for more info on dosing, side effects and...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.